Biohaven Pharmaceutical Holding Company Ltd.
BHVN$1.04B
Small CapNASDAQPharmaceutical Preparations🇺🇸North AmericaNEW HAVEN256 employees
Drugs in Pipeline
7
Phase 3 Programs
5
Upcoming Catalysts
4
Next Catalyst
Next month
Market Overview
Stock performance and key metrics
BHVN News
Catalyst Timeline
4 upcoming, 0 past
Drug Pipeline
BHV-7000
Bipolar Disorder
Taldefgrobep Alfa
Obesity
BHV-8000
Parkinson Disease
Verdiperstat
Multiple System Atrophy
troriluzole
Spinocerebellar Ataxias
BHV-1510
Solid Tumor
BHV-2100
Migraine
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
BHV-7000 | Phase 3 | Bipolar Disorder | - | - |
Taldefgrobep Alfa | Phase 3 | Obesity | - | - |
BHV-8000 | Phase 3 | Parkinson Disease | - | - |
Verdiperstat | Phase 3 | Multiple System Atrophy | - | - |
troriluzole | Phase 3 | Spinocerebellar Ataxias | - | - |
BHV-1510 | Phase 2 | Solid Tumor | - | - |
BHV-2100 | Phase 2 | Migraine | - | - |
Catalyst Verdict
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply